Foreword: Learn from Others |
|
xi | |
About BGI and Prof. Yang |
|
xv | |
Acknowledgments |
|
xvii | |
|
|
1 | (4) |
|
2 Evolution Of Life On Earth |
|
|
5 | (20) |
|
|
5 | (9) |
|
|
14 | (11) |
|
3 Adaptation Of Life To Extreme Conditions |
|
|
25 | (22) |
|
|
27 | (16) |
|
Cell Biology and Genomics of Adaptation |
|
|
43 | (4) |
|
4 Homo Sapiens ("Us"): Strengths And Weaknesses |
|
|
47 | (42) |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
53 | (6) |
|
|
59 | (2) |
|
|
61 | (1) |
|
|
62 | (3) |
|
|
65 | (2) |
|
|
67 | (2) |
|
|
69 | (2) |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (2) |
|
|
74 | (1) |
|
|
75 | (4) |
|
Sapiens Challenges and Weaknesses |
|
|
79 | (3) |
|
What is it That Kills Homo Sapiens? |
|
|
82 | (2) |
|
The Human Brain, The Big Differentiator |
|
|
84 | (5) |
|
5 The Human Microbiome: How Our Health Is Impacted By Microorganisms |
|
|
89 | (18) |
|
Diabetes and Intestinal Microbes |
|
|
96 | (1) |
|
Intestinal Microorganisms and Immune System |
|
|
97 | (1) |
|
|
98 | (1) |
|
Intestinal Microorganisms and Antibiotic Use |
|
|
99 | (1) |
|
Intestinal Microbiology and Neurodevelopment |
|
|
99 | (1) |
|
Intestinal Microorganisms and Obesity |
|
|
100 | (1) |
|
Intestinal Microorganisms and Hypertension |
|
|
100 | (1) |
|
Intestinal Microbes and Chronic Inflammatory Bowel Disease |
|
|
100 | (1) |
|
Intestinal Microorganisms and Tumors |
|
|
101 | (1) |
|
Intestinal Microbes and Neurobehavioral Diseases |
|
|
101 | (1) |
|
Intestinal Microbiology and Biological Clock |
|
|
102 | (1) |
|
Intestinal Microbes and Human Mental Health |
|
|
103 | (4) |
|
6 Animals With Connection To Human Knowledge, Health, And Performance |
|
|
107 | (144) |
|
|
107 | (1) |
|
HGP specific Model Organisms |
|
|
108 | (9) |
|
Biomedical Model Organisms |
|
|
117 | (26) |
|
The Fruit Fly (Drosophila melanogaster) |
|
|
117 | (7) |
|
|
124 | (8) |
|
California Sea Slug (Aplysia californica) |
|
|
132 | (5) |
|
The Zebrafish (Danio rerio) |
|
|
137 | (6) |
|
|
143 | (43) |
|
The Domestic Pig (Sus domesticus) |
|
|
146 | (8) |
|
The Elephant (Loxodonta africana and Elephas maximus) |
|
|
154 | (7) |
|
The Naked Mole Rat (Heterocephalus glaber) |
|
|
161 | (6) |
|
The Jellyfish (Scyphozoa, etc.) |
|
|
167 | (4) |
|
The Cone Snail (Conus magus, etc.) |
|
|
171 | (3) |
|
The Komodo Dragon (Varanus komodoensis) |
|
|
174 | (3) |
|
The Gila Monster (Heloderma suspectum) and Salamander (Urodela) |
|
|
177 | (4) |
|
The Burmese Python (Python bivittatus) |
|
|
181 | (5) |
|
6C Animals With Potential To Improve Human Performance |
|
|
186 | (65) |
|
The Atlantic Bay Scallop (Argopecten irradians/Pectinidae) |
|
|
187 | (5) |
|
|
192 | (4) |
|
The Pit Vipers (Crotalinae] |
|
|
196 | (2) |
|
The Vampire Bat (Desmodus rotundus) |
|
|
198 | (3) |
|
Electric Eel (Electrophorus electricus] and Ghost Knifefish (Apteronotidae) |
|
|
201 | (4) |
|
The Dolphin (Cetacea/Delphinidae, etc.) |
|
|
205 | (5) |
|
Hummingbirds (Trochilidae) |
|
|
210 | (5) |
|
The Peregrine Falcon (Falco peregrinus) |
|
|
215 | (2) |
|
The Bar-Headed Goose (Anser indicus) |
|
|
217 | (5) |
|
The Wild Yak (Bos mutus) and Domestic Yak (Bos grunniens) |
|
|
222 | (4) |
|
The Penguins (Sphenisciformes) |
|
|
226 | (6) |
|
The Polar Bear (Ursus maritimus) |
|
|
232 | (4) |
|
The Cheetah (Acinonyx jubatus) |
|
|
236 | (3) |
|
The Dog (Canis lupus familiaris) |
|
|
239 | (5) |
|
The Platypus (Ornithorhynchus anatinus) |
|
|
244 | (7) |
|
7 Current Use And Future Promise Of Genetic Engineering |
|
|
251 | (30) |
|
|
264 | (2) |
|
|
266 | (1) |
|
|
267 | (12) |
|
|
276 | (3) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
280 | (1) |
|
8 Animal Connection Challenges |
|
|
281 | (52) |
|
|
282 | (1) |
|
|
282 | (1) |
|
Measures to Reduce Pandemic Risk throughout History |
|
|
283 | (2) |
|
Viral Pathogens and Therapies |
|
|
285 | (2) |
|
|
287 | (10) |
|
Virus classification and the importance of animal transmissions |
|
|
287 | (7) |
|
|
294 | (3) |
|
|
297 | (23) |
|
|
297 | (2) |
|
|
299 | (1) |
|
|
300 | (2) |
|
Coronavirus history and COVID-19 origin |
|
|
302 | (3) |
|
|
305 | (3) |
|
COVID-19 clinical picture |
|
|
308 | (3) |
|
How epidemiologists hope to control and mitigate COVID-19 |
|
|
311 | (9) |
|
Are animals better protected against viral attacks, and what could we learn by studying animal models? |
|
|
320 | (2) |
|
How molecular biologists hope to develop vaccines and drug treatments |
|
|
322 | (7) |
|
Societal and economic consequences |
|
|
329 | (4) |
Conclusion |
|
333 | (4) |
Appendix: Metric or US "Customary Units" System? |
|
337 | (6) |
References |
|
343 | (28) |
Index |
|
371 | |